Innovent Biologics, Inc. (HKG:1801)

Innovent Biologics Statistics

Total Valuation

HKG:1801 has a market cap or net worth of HKD 148.36 billion. The enterprise value is 131.20 billion.

Market Cap	148.36B
Enterprise Value	131.20B

Important Dates

The last earnings date was Thursday, March 26, 2026.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:1801 has 1.74 billion shares outstanding. The number of shares has increased by 6.98% in one year.

Current Share Class	1.74B
Shares Outstanding	1.74B
Shares Change (YoY)	+6.98%
Shares Change (QoQ)	+5.48%
Owned by Insiders (%)	6.40%
Owned by Institutions (%)	41.95%
Float	1.61B

Valuation Ratios

The trailing PE ratio is 163.47 and the forward PE ratio is 35.77.

PE Ratio	163.47
Forward PE	35.77
PS Ratio	10.22
PB Ratio	6.89
P/TBV Ratio	7.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	144.92
EV / Sales	9.04
EV / EBITDA	130.15
EV / EBIT	194.78
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.62, with a Debt / Equity ratio of 0.15.

Current Ratio	2.62
Quick Ratio	2.38
Debt / Equity	0.15
Debt / EBITDA	2.81
Debt / FCF	n/a
Interest Coverage	8.82

Financial Efficiency

Return on equity (ROE) is 5.01% and return on invested capital (ROIC) is 17.28%.

Return on Equity (ROE)	5.01%
Return on Assets (ROA)	1.49%
Return on Invested Capital (ROIC)	17.28%
Return on Capital Employed (ROCE)	2.42%
Weighted Average Cost of Capital (WACC)	5.52%
Revenue Per Employee	1.93M
Profits Per Employee	120,680
Employee Count	7,502
Asset Turnover	0.44
Inventory Turnover	2.90

Taxes

In the past 12 months, HKG:1801 has paid 28.22 million in taxes.

Income Tax	28.22M
Effective Tax Rate	3.02%

Stock Price Statistics

The stock price has increased by +118.95% in the last 52 weeks. The beta is 0.24, so HKG:1801's price volatility has been lower than the market average.

Beta (5Y)	0.24
52-Week Price Change	+118.95%
50-Day Moving Average	83.86
200-Day Moving Average	88.02
Relative Strength Index (RSI)	54.08
Average Volume (20 Days)	11,838,728

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1801 had revenue of HKD 14.51 billion and earned 905.34 million in profits. Earnings per share was 0.52.

Revenue	14.51B
Gross Profit	11.09B
Operating Income	781.31M
Pretax Income	933.56M
Net Income	905.34M
EBITDA	1.12B
EBIT	781.31M
Earnings Per Share (EPS)	0.52

Balance Sheet

The company has 20.29 billion in cash and 3.13 billion in debt, with a net cash position of 17.15 billion or 9.89 per share.

Cash & Cash Equivalents	20.29B
Total Debt	3.13B
Net Cash	17.15B
Net Cash Per Share	9.89
Equity (Book Value)	21.54B
Book Value Per Share	12.58
Working Capital	15.16B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	340.31M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 76.42%, with operating and profit margins of 5.38% and 6.24%.

Gross Margin	76.42%
Operating Margin	5.38%
Pretax Margin	6.43%
Profit Margin	6.24%
EBITDA Margin	7.69%
EBIT Margin	5.38%
FCF Margin	n/a

Dividends & Yields

HKG:1801 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.98%
Shareholder Yield	-6.98%
Earnings Yield	0.61%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4